Is combined estrogen/progestogen hormone therapy worth the risk?
作者信息
Sturdee David W, MacLennan Alastair H
出版信息
Climacteric. 2003 Sep;6(3):177-9.
PMID:14567764
Abstract
摘要
相似文献
1
Is combined estrogen/progestogen hormone therapy worth the risk?雌激素/孕激素联合激素疗法值得冒风险吗？
Climacteric. 2003 Sep;6(3):177-9.
2
Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.绝经后激素治疗与乳腺癌风险：一种相反的观点
Menopause. 2008 Mar-Apr;15(2):393-400. doi: 10.1097/gme.0b013e31812f7b55.
3
4
Do risks of hormone therapy persist after discontinuation?激素治疗停药后风险仍会持续存在吗？
J Fam Pract. 2008 Jun;57(6):366, 369.
5
Reducing the problems of the progestogen.减少孕激素的问题。
Climacteric. 2006 Aug;9(4):241-3. doi: 10.1080/13697130600877522.
6
Postmenopausal hormone therapy and breast cancer: what is the problem?绝经后激素治疗与乳腺癌：问题何在？
Maturitas. 2005 May 16;51(1):75-82. doi: 10.1016/j.maturitas.2005.02.017.
7
Postmenopausal hormone therapy and breast cancer.绝经后激素治疗与乳腺癌
Prescrire Int. 2009 Apr;18(100):66-7.
8
9
Estrogen-progestin increases breast cancer risk.
J Fam Pract. 2000 Apr;49(4):301-2.
10
Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.BRCA1 突变携带者的绝经激素治疗：不确定性与谨慎态度。
J Natl Cancer Inst. 2008 Oct 1;100(19):1341-3. doi: 10.1093/jnci/djn327. Epub 2008 Sep 23.
Zotero 插件